Ralf A. Hilger
- Molecular Biology top 5%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Hematology top 2%
- Cancer Research top 5%
- Co-authors
- M. E. ScheulenDirk StrumbergS. SeeberHeike RichlyE. BrendelBrian SchwartzR. VoigtmannD. Voliotis
- Topics
- Colorectal Cancer Treatments and Studies (13 papers)Cancer Treatment and Pharmacology (12 papers)Melanoma and MAPK Pathways (8 papers)
- Cited by
- OncologyHematologyHepatology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ralf A. Hilger
81 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 1.3k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 618
- Hematology 410
- Cancer Research 374
Countries citing papers authored by Ralf A. Hilger
This map shows the geographic impact of Ralf A. Hilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf A. Hilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf A. Hilger more than expected).
Fields of papers citing papers by Ralf A. Hilger
This network shows the impact of papers produced by Ralf A. Hilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf A. Hilger. The network helps show where Ralf A. Hilger may publish in the future.
Co-authorship network of co-authors of Ralf A. Hilger
This figure shows the co-authorship network connecting the top 25 collaborators of Ralf A. Hilger. A scholar is included among the top collaborators of Ralf A. Hilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf A. Hilger. Ralf A. Hilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 69 | |
| 6 | Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin. | 11 |
| 7 | 12 | |
| 8 | 2 | |
| 9 | 68 | |
| 10 | 25 | |
| 11 | 99 | |
| 12 | 84 | |
| 13 | 5 | |
| 14 | 17 | |
| 15 | 30 | |
| 16 | 12 | |
| 17 | 8 | |
| 18 | 55 | |
| 19 | Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells. | 5 |
| 20 | 5 |
About Ralf A. Hilger
Ralf A. Hilger is a scholar working on Oncology, Physiology and Hematology, having authored 83 papers that have together received 3.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (12 papers) and Melanoma and MAPK Pathways (8 papers). The work is most often cited by research in Oncology (1.2k citations), Hematology (410 citations) and Hepatology (240 citations). Ralf A. Hilger has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include M. E. Scheulen, Dirk Strumberg, S. Seeber, Heike Richly, E. Brendel, Brian Schwartz, R. Voigtmann, D. Voliotis, N. Schleucher and Markus Faghih. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.